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Abstract 
Multiple Sclerosis (MS) is an inflammatory neurodegenerative disease, where neural progenitor 
cell (NPC) transplantation has been suggested as a potential neuroprotective therapeutic strategy. 
Since the effect of inflammation on NPCs is poorly known, their effect on the survival and 
functionality of human NPCs were studied. Treatment with interleukin (IL)-6, tumor necrosis 
factor (TNF)-α and interferon (IFN)-γ did not induced cytotoxicity, but IFN-γ treatment showed 
decreased proliferation and neuronal migration. By contrast, increased proliferation and inhibition 
of electrical activity were detected after TNF-α treatment. Treatments induced secretion of 
inflammatory factors. Inflammatory cytokines appear to modulate proliferation as well as the 
cellular and functional properties of human NPCs.  
Keywords: cytokines, human pluripotent stem cells, IFN-γ, IL-6, microelectrode array, multiple 
sclerosis, neural cells, TNF-α 
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1. Introduction
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) 
characterized by presence of focal inflammatory lesions associated with oligodendrocyte and 
neuron damage, astrogliosis, demyelination and axonal degeneration (Weissert, 2013). In MS 
lesions, the predominant cell types are T-lymphocytes and macrophages which are involved in the 
development of tissue damage. Additionally, activated astrocytes and microglia contribute to 
lesion development by secreting cytokines and other inflammatory mediators (Weissert, 2013). 
The demyelinated areas can be partly repaired by remyelination in the early stage of the disease, 
but this mechanism is impaired in the later stage of the disease (Kremer, Küry and Dutta, 2015). 
As damage to neurons and oligodendrocytes and failure of the remyelination process are the 
neuropathological hallmarks of MS, replacement therapies using exogenous neural progenitor 
cells (NPC) have been suggested to be a promising approach to promote neuroprotection (Pluchino 
et al., 2009). In fact, multiple preclinical studies in animal models of MS have shown a beneficial 
effect of on the disease course (Giusto et al., 2014). One of the main obstacles in designing 
transplantation therapies for MS is the inflammatory nature of the disease, which has been shown 
to hinder endogenous remyelination (Pluchino et al., 2009). On the other hand, it has become 
evident that some degree of neuroinflammation is necessary for remyelination (Yong and Marks, 
2010), since activated immune cells present at the site of damage may produce neurotrophic factors 
as well as stimulate their production in neurons and glial cells (Dooley, Vidal and Hendrix, 2014). 
The transplanted cells will face the same environmental challenge when entering the damaged 
brain area. 
In MS, lymphocytes and macrophages as well as CNS-resident cells such as astrocytes and 
microglia secrete cytokines and chemokines that may promote the inflammation but are also able 
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to induce direct neuronal damage (Lassmann, 2014). Interferon (IFN)-γ, tumor necrosis factor 
(TNF)-α and interleukin (IL)-6 are classical proinflammatory cytokines that play a major role in 
the pathogenesis of MS by promoting neuroinflammation as well as inducing neurotoxicity 
(Ellwardt and Zipp, 2014; Janssens, Slaets and Hellings, 2015). All of these cytokines are detected 
in perivascular lesions of the MS patients (Cannella and Raine, 1995; Schönrock, Gawlowski and 
Brück, 2000; McFarland and Martin, 2007). TNF-α and IFN-γ is secreted from the T helper (Th) 
1 and Th17 cells, while secretion of IL-6 is associated to astrocytes. Their levels have been shown 
to increase in the blood and cerebrospinal fluid especially during the active phase of the disease 
(Martins et al., 2011; Becher, Spath and Goverman, 2016). Previous preclinical and clinical studies 
of MS have also shown that proinflammatory cytokines may have beneficial roles in MS, since 
administration of monoclonal antibodies against IFN-γ to mice with experimental autoimmune 
encephalomyelitis, an animal model of MS, increased the morbidity rate (Billiau et al., 1988). 
Additionally, a clinical trial of anti-TNF-α targeted therapy showed significantly more aggressive 
course among the treated patients than among the placebo-treated patients (Jager et al., 2009). 
There are several reports on the in vitro effects of cytokine stimulation on the viability, 
proliferation, and differentiation of human and rodent NPCs (Ben-Hur et al., 2003; Wong, 
Goldshmit and Turnley, 2004; Sheng et al., 2005; Widera et al., 2006; Johansson, Price and Modo, 
2008; Walter et al., 2011; Ye et al., 2013). These studies show very contradictory results because 
of the different study designs, the origin and type of used NPC cultures and the outcome measures 
used. It is, however, reasonable to conclude that the detrimental inflammatory effects of cytokines 
on NPCs studied in vitro are in line with the low success of the transplantation experiments as 
relatively poor cell survival, migration, differentiation, and maturation have been reported in vivo 
(Ben-Hur et al., 2003; Wong, Goldshmit and Turnley, 2004; Liu, Lin and Tzeng, 2005; Sheng et 
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al., 2005). Even though these challenges exist, reported alleviation of functional deficits and 
delayed disease progression in animal experiments (Giusto et al., 2014) encourage continuation 
these in vitro studies. 
The effects of cytokines on clinically relevant cell types should be studied in detail as there are 
differences in cellular responses between human and rodent NPCs (Sheng et al., 2005; Widera et 
al., 2006). For transplantation therapies, human-derived NPCs are needed. These can be obtained 
from adult nervous tissue, fetal tissue, or pluripotent stem cell origins (Kim and de Vellis, 2009). 
Adult and fetal cell sources are, however, difficult to harvest in large amounts. Thus, pluripotent 
cells, including both induced pluripotent stem (iPS) cells and embryonic stem cells (ESCs), are 
seen as a potential cell source for transplantation therapies because of their upscaling and 
differentiation properties (Erceg et al., 2011; Mattis and Svendsen, 2011). Prior to transplantation 
experiments, it is vital to study the effects of inflammation in vitro on the survival, proliferation, 
and maturation on the selected cell type. Importantly, the effects of cytokines should also be 
studied on a functional level as detrimental effects can compromise cell signaling before any effect 
on the genotype or phenotype is detectable (Ylä-Outinen et al., 2010).  
Previous studies have focused on the cytokine mediated effect on cellular level, but as far as we 
know, no studies are available that shows also their effect on the neuronal network activity. Here, 
we studied the effects of three major inflammatory cytokines, namely, IFN- γ, TNF-α, and IL-6, 
on the viability and functionality of human pluripotent stem cell (hPSC)-derived neural cells in 
vitro. In addition, we aimed to determine how these cytokines affect differentiation, proliferation, 
expression of cytokine receptors, and secretion of different growth factors, chemokines, and 
cytokines. The effect of the cytokines was studied at wide concentration range (1, 10 and 100 
ng/ml) to reveal their effect in the low and high concentrations. Especially, the lower 
6 
concentrations are of interest, since cytokines are detected in the blood  and CSF of MS patient  at 
the pg/ml level (Cannella and Raine, 1995; Schönrock, Gawlowski and Brück, 2000; Martins et 
al., 2011). Moreover, as most of the in vitro studies of NPCs have been carried out with NPC 
aggregates, comparison of the cytokine effect between in singe cell and aggregate culture were 
also included.  According to our results, the present study bring novel information on how these 
cytokines modulates proliferation and both cellular and functional properties of human NPCs in 
vitro. 
2. Materials and methods
2.1. Experimental design of the study 
This study was composed of two sets of experiments, Exp1 and Exp2, in which the responses of 
human embryonic stem cell (hESC)-derived NPCs to the cytokines IFN-γ, TNF-α and IL-6 were 
studied both in aggregate and in single cell culture (Fig 1A). In all experiments, hESCs were 
differentiated toward a neural lineage for 8-18 weeks, resulting in cultures containing both neurons 
and astrocytes (Fig 1 B-E) (Lappalainen et al., 2010). In experiments with aggregates, the effects 
of cytokines on cell viability and neuronal characteristics were studied through an analysis of 
LIVE/DEAD cell viability, time-lapse imaging, immunocytochemistry, proliferation 
measurements with an immunocytochemical staining procedure, gene expression of cytokine 
receptors and cell culture media for the secreted growth factors, cytokines, and chemokines (Exp 
1). Additionally, the effects of cytokines on spontaneously functional neuronal networks were 
studied using microelectrode arrays (MEA). In single NPC studies, the effects of cytokines on cell 
viability and neuronal characteristics were studied using time-lapse imaging and analysis, 
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immunocytochemistry, and proliferation measurements with an ELISA-based BrdU proliferation 
analysis (Exp 2).  
2.2. Neuronal cell differentiation of hESC 
The hESC lines HS181, derived at Karolinska Institute  (Hospital Huddinge, Stockholm, Sweden, 
kindly provided by Prof. Hovatta), and 08/023, 06/040, 08/023, derived at Regea (University of 
Tampere, Tampere, Finland), were used for neuronal differentiation. The study has ethical 
approval from the ethics committee of the Karolinska Institute to derive, characterize, and 
differentiate the hESC lines, and from the ethics committee of the Pirkanmaa Hospital District to 
culture the hESC lines derived at the Karolinska Institute and to derive and culture new hESC 
lines. Furthermore, a supportive statement from the ethical committee of the Hospital District of 
Pirkanmaa allows derivation, culturing, and differentiation of hESC lines (R05116).  
hESC lines culturing and neural differentiation was performed as previously described (Hovatta et 
al., 2003; Lappalainen et al., 2010; Rajala et al., 2010; Skottman, 2010). Briefly, hESC colonies 
were plated on 6-well Low Cell Bind plates (NuncTM, Thermo Fisher Scientific) and cultured in 
suspension culture in neural differentiation medium (NDM) including DMEM F12 Neurobasal 
medium, 2 mM Glutamax, 20 μl/ml B-27 supplement, 10 μl/ml N2 supplement (all from Gibco 
Invitrogen), and 0.25 % penicillin/streptomycin (Lonza Group Ltd.), supplemented with 20 ng/ml 
basic fibroblast growth factor (bFGF) (R&D Systems). 
2.3. Cell plating and cytokine stimulation 
NPCs were plated on human laminin (10 μg/ml, Sigma-Aldrich, St. Louis, MO, USA)-coated 24- 
or 48-well plates (NuncTM, Thermo Fisher Scientific) as aggregates (Experiment 1) or single 
NPCs (Experiment 2). For aggregate culture, neurospheres were mechanically cut into small 50-
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200 µm in diameter clusters, while for single cells cultures, neurospheres were dissociated with 
TrypLE Select enzyme (Invitrogen). The cells were allowed to grow for two days before cytokine 
stimulation. The adherent NPCs were treated with 0, 1, 10, or 100 ng/ml E. coli-derived 
recombinant human TNF-α, IFN-γ, or IL-6 (R&D systems, Minneapolis, MN, USA) for 12 to 72 
h before the cells were collected or fixed for analysis. 
2.4. Gene expression analyses of cytokine receptors 
The gene expression levels of cytokine receptors for IFN-γ (IFNGR1, IFNGR2), TNF-α 
(TNFRSF1A, TNFRSF1B), and IL-6 (GP130, IL6R) and the housekeeping gene β-actin in NPCs 
(Experiment 1) were studied with reverse transcription PCR. RNA was isolated from pooled 
samples of two wells and analyses were done from single sample. Total cellular RNA was isolated 
from stored cell lysates using an RNeasy Micro Kit (Qiagen, Germany) according to the 
manufacturer’s instructions. DNA was removed with a Qiagen RNase-Free DNase set. The total 
RNA was eluted with nuclease-free water, and the samples were stored at -70°C. The purity and 
concentration of the RNA were measured with a NanoDrop (Thermo Scientific, USA). 
A total of 100 ng of RNA was reverse transcribed to complementary DNA (cDNA) using a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, USA) with random hexamer 
primers, following the standard protocol. Ten nanograms of cDNA was used in a 20 µl total 
reaction volume for the PCR reactions. The final concentrations of the reagents were as follows: 
1 × reaction buffer (10 mM Tris-HCl, 1.5 mM MgCl2, 50 mM KCl, 0.1 % Triton-X-100), dNTP 
mix (400 nm), DyNAzyme™ II DNA Polymerase (0.08 U/ml) (Finnzymes Oy, Finland) and 
reverse and forward primers (200 nM, TAGC, Copenhagen, Denmark). The amplification was 
performed in a Biometra T-Personal thermal cycler using the following cycling conditions: 
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denaturation, 95 °C for 10 min, amplification 35 cycles: 95 °C for 1 min, 55-60 °C (annealing 
temperature) for 1 min and 72 °C for 1 min. The amplified samples were characterized with 1.5-
2.5 % agarose gel. The primers and annealing temperatures used are listed in Supplementary table 
1. 
2.5. Cell viability analysis  
A LIVE/DEAD® Cell Viability/Cytotoxicity Kit for mammalian cells (Molecular Probes, 
Invitrogen) was used to directly measure the cell viability of NPCs (Experiment 1). Calcein-AM 
and ethidium homodimer-1 were diluted in NDM and incubated with cells for 30 min at room 
temperature (RT) in the dark. The cells were imaged immediately under a fluorescence microscope 
(IX51, Olympus, Finland) and photographed (DP71 camera, Olympus). Calcein-AM stains living 
cells and emits green light at 488 nm, whereas ethidium homodimer-1 stains dead cells and emits 
red light at 568 nm. The cells were imaged with a 20× objective in at least 4 non-overlapping fields 
for each of two duplicate wells.  
NPCs (Experiment 1 and 2) were monitored with time-lapse imaging using the Cell-IQ cell 
culturing platform (ChipMan Technologies, Finland), which allows continuous monitoring of 
selected cells as described previously (Supplementary Fig. 1.) (Narkilahti et al., 2007; Nat et al., 
2007; Huttunen et al., 2011). One day after the cells were plated, the 24-well plates were 
transferred into a time-lapse imaging system and the cells were imaged for 24 h to obtain a baseline 
recording. The cells of interest were selected for monitoring in 500 µm x 670 µm areas using an 
all-in-focus imaging system, and all areas of interest were imaged at 45-min intervals. After the 
baseline measurement and the start of cytokine stimulation, the plates were measured for an 
additional 72 h. The captured images were stored in JPEG format for later use. The alterations in 
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NPC number and neuronal length were analyzed with Cell-IQ Analyzer software. In total, 27 
images per cytokine per concentration were used in the analysis over 72h follow-up.  
2.6. Neuronal network functionality analysis 
The effects of cytokines on spontaneously functional networks were studied using MEA 
technology. First neuronal cells were plated in MEA dishes (200/30iR-Ti, Multichannel Systems, 
Reutlingen, Germany, MCS), as described earlier (Heikkilä et al., 2009). In this experiment, the 
plated cells were allowed to grow and develop into functional networks for three weeks before 
cytokine stimulation. Recordings were obtained with an MEA60 amplifier (MCS), and the 
detection of spikes was performed with MC_Rack software (MCS). The MEA measurements were 
performed one day before cytokine stimulation and 12, 24, 48, and 72 h thereafter without 
changing the culture media between measurements. The number of MEA wells per cytokine per 
cytokine concentration was 3-4. At each timepoint, the neuronal networks were measured for 5 
min. 
2.7. Immunocytochemistry 
The effects of cytokines on neural differentiation were characterized immunocytochemically by 
staining cells positive for microtubule-associated protein-2 (MAP-2), nestin, and glial fibrillary 
acidic protein (GFAP) after cytokine stimulation (Experiments 1 and 2). Briefly, the cytokine-
treated or control cells were fixed with 4 % paraformaldehyde (PFA) for 15 min at RT and washed 
twice with phosphate-buffered saline (PBS). For blocking, PBS with 10 % normal donkey serum 
(NDS), 1 % bovine serum albumin (BSA), and 0.1 % Triton X-100 was used. Primary antibodies 
were diluted in a fresh washing solution of 1 % NDS, 1 % BSA and 0.1 % Triton X-100 in PBS 
and incubated with the cells overnight at +4 °C. Secondary antibodies were diluted with fresh 1 % 
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BSA in PBS and incubated with the cells for 1 h at RT in the dark. The cells were then washed 
with PBS and phosphate buffer (PB) solution, dried, and mounted with Vectashield® (Vector 
Laboratories Inc., UK) containing diamidino-2-phenylindole (DAPI).  
The primary antibodies for NPCs were rabbit anti-MAP-2 IgG (1:400, Millipore), mouse anti-
nestin IgG (1:100, Chemicon-Millipore), and sheep anti-GFAP IgG (1:1000, R&D Systems). The 
secondary antibodies used were Alexa Fluor 488 donkey anti-rabbit IgG (1:400, Invitrogen), Alexa 
Fluor 488 goat anti-mouse IgG (1:400, Invitrogen), Alexa Fluor 568 donkey anti-sheep IgG (1:400, 
Invitrogen), and Alexa Fluor 568 donkey anti-mouse IgG (1:400; Invitrogen). The cells were 
imaged using an Olympus IX51 phase-contrast microscope equipped with fluorescence optics and 
an Olympus DP71 camera. The cells were counted in at least from 4 non-overlapping fields of one 
well obtained with a 20× objective. The positive cells were counted as a percentage of all DAPI-
positive cells, and more than 100 DAPI-positive cells were counted from each group. 
 
2.8. Cell proliferation analysis 
Cell proliferation analysis for aggregate culture was performed using a Ki-67 
immunocytochemical staining procedure (experiment 1), while single cell culture analysis 
(experiment 2) was performed using an ELISA-based BrdU kit (Roche Applied Science). 
Proliferation in the aggregate culture was studied immunocytochemically using the proliferation 
marker rabbit anti-Ki-67 IgG (1:400, Chemicon International) and mouse anti-nestin IgG (1:100, 
Chemicon-Millipore). Staining and imaging were performed as described in the 
immunocytochemistry section. 
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The proliferation rate of single NPCs was measured 72 h after cytokine stimulation using a 
colorimetric enzyme-linked immunosorbent assay (ELISA)-based BrdU kit (Roche, Basel, 
Switzerland). Briefly, single NPCs were incubated with BrdU (final concentration 10 μM) in basic 
NDM for 24 h. On the following day, the cells were trypsinized and transferred to a 96-well plate. 
The plate was centrifuged, after which the cells were dried and fixed with FixDenat solution. The 
cells were incubated with anti-BrdU-peroxidase for 90 min at RT. Thereafter, substrate solution 
was added and the colorimetric reactions were stopped with a stop solution of 1 M H2SO4. Finally, 
the absorbance was measured at 450 nm in a Victor2 1420 Multilabel Counter ELISA reader 
(PerkinElmer-Wallac). The cells were collected from one well and 6 technical replicates were 
used. 
2.9. Culture medium analysis by Luminex 
The culture media from treated and control cells were collected and stored at -70 °C. Medium 
samples pooled together from two wells and in the analysis two technical analyses were used. The 
levels of the cytokines IL-4, IL-6 and IL-10; the chemokines interferon gamma-induced protein 
10 (IP-10) and monocyte chemotactic protein-1 (MCP-1); and the growth factors epidermal growth 
factor (EGF), bFGF, nerve growth factor (NGF), platelet-derived growth factor subunit BB 
(PDGF-BB), and vascular endothelial growth factor (VEGF) in the cell culture supernatant were 
analyzed with a Procarta® Cytokine Human Assay Kit (Panomics, Affymetrix Inc., Santa Clara, 
USA). Briefly, mixed antibody beads were added to each well as well as standards and medium 
and incubated for 60 min at RT. Detection antibody solution was added, and the plate was 
incubated for 30 min. Thereafter, streptavidin-PE solution was added and incubated for 30 min. 
Finally, reading buffer was added and the samples were run with a Luminex instrument (Bio- 
PlexTM 200 System, based on Luminex® xMAP Technology). All the data were collected and 
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analyzed using Bio-Plex manager software 4.1 (Bio-Rad laboratories). Five-parameter regression 
models were used to calculate the concentrations of the molecules. 
2.10. Statistical analysis 
Data of the cell number analysis from live imaging were conducted with STATA program 
(StataCorp LP, College station, USA), while neurite length data were analyzed with SPSS version 
21.0 (Armonk, NY: IBM Corp). The cell number data from time-lapse imaging were analyzed 
with a Poisson regression model with covariates which were determined from the baseline 
measurement (24 h before cytokine addition) using a linear regression model. Neurite length data 
were analyzed with ANOVA. Owing to the unequal variance of the neurite lengths, the length data 
were transformed to the log scale. Covariates were calculated as in the cell number analysis, with 
a linear regression model using transformed log values.  
Group comparisons of proliferation analysis, immunocytochemistry, and active channels in the 
MEA analysis were performed with a Mann-Whitney U test. Bonferroni’s correction was 
performed in the case of multiple comparisons, and p-values less than 0.05 were considered 
significant. All the values were expressed as mean ± SD. 
3. Results
3.1. IFN-γ and TNF-α did not induce cell death, but prevented migration of human NPCs 
The effects of inflammatory cytokines on the viability and neural characteristics of NPCs were 
studied with a LIVE/DEAD cell viability assay, time-lapse imaging using Cell-IQ and 
immunocytochemistry (Fig 1, Exp 1). Also the gene expression of cytokine receptors IFNGR1, 
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IFNGR2, TNFRSF1A, TNFRSF1B, IL-6R, and GP130 was analyzed in the cultured NPCs. All 
the cytokine receptors except TNFRSF1B were detected in control and cytokine-treated cells.  (Fig 
2E).  
In treated samples (Fig 2 B, C, D), an increased number of dead cells (red color) compared with 
untreated controls was not detected (Fig 2 A). In all the samples, most of the cells were viable 
(green color, Fig 2A-D, supplementary Fig. 2). Since the cytokines did not affect the viability of 
the NPCs, the effect of the cytokines on neuronal migration from the attached aggregates was 
determined next using time-lapse imaging (Fig 3 A-E; Supplementary Video 1 and Supplementary 
Video 2). Cell number analyses (Fig 3 A-C) showed that IFN-γ at concentration of 10 ng/ml 
(coefficient -0.4, p=0.040) and TNF-α at concentration 100 ng/ml (coefficient -0.6, p=0.005) 
decreased the neuronal migration in comparison to untreated samples. IL-6 did not have any effect 
on the neuronal migration, and therefore IL-6 was excluded from the subsequent analyses. Neurite 
length analyses (Fig 3 D-E) showed that IFN-γ at concentrations of 1 ng/ml and 10 ng/ml (p=0.005 
and p=0.010, respectively) inhibited the growth of the neurites, whereas TNF-α did not have any 
impact (p>0.05 in all cases). 
To determine whether cytokines promote NPC proliferation, cultures were double labeled for the 
proliferation marker Ki-67 and the neural stem/progenitor cell marker Nestin at the 72h timepoint 
(Fig 3 G-I). The number of Ki-67-positive cells was counted as a percentage of DAPI-positive 
cells (Fig 3F). IFN-γ at concentrations of 10 ng/ml (4.4 ± 6.4 vs. 19.0 ± 2.3 %, p=0.021) and 100 
ng/ml (8.4 ± 2.9 vs. 19.0 ± 2.3 %, p=0.021) significantly decreased, whereas TNF-α at 
concentration 100 ng/ml (25.4 ± 4.4 vs. 19.0 ± 2.3 %, p=0.021) significantly increased, the 
proliferation of the NPCs compared with the control.  
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Immunocytochemical staining was performed on treated and untreated samples in order to 
characterize the effects of cytokines on neural differentiation. In the control conditions, NPCs, 
Nestin (62.5+5.0 %) and MAP-2 (29.2+12.8 %)-positive neuronal cells were detected in all the 
samples studied (Fig. 1 B-D). Additionally, some GFAP-positive astrocytes (3.4+4.7 %) were 
detected in the untreated samples (Fig. 1 E).   No obvious difference of neural differentiation 
among controls and cytokine treated NPCs was detected (Supplementary Fig. 3).  
3.2. The cytokine treatments caused inhibition of spontaneous neuronal network activity 
The effects of IFN-γ and TNF-α on spontaneous neuronal network activity were studied using 
microelectrode arrays (MEA). For that purpose, differentiated NPCs were cultured for three weeks 
on MEA dishes to allow them to develop into functional networks, and thereafter they were treated 
with cytokines. TNF-α (100 ng/ml)-treated cultures showed decreased activity after 72h (Fig 4 G), 
but IFN-γ did not showed any statistical significance. A representative example of control (Fig 4 
A-C) vs. 100 ng/ml TNF-α (Fig 4 D-F) is shown as reduction of white-labeled active electrodes 
and as a representative activity recording (Fig 4 H).  
3.3. Cytokine stimulates secretion of inflammatory molecules from NPCs 
To understand whether cytokines can influence the immunomodulatory responses of NPCs, the 
secretion of cytokines, chemokines, and growth factors was analyzed at the protein level from 
conditioned medium (Table 1, Supplementary Fig 4.). Five out of 11 studied molecules (IL-4, 
bFGF, NGF, and PDGF-BB) were undetectable in both the control and treated conditions. The 
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EGF was already detectable at a low level in the control condition, and cytokine stimulation did 
not have a significant influence on its secretion. IFN-γ induced secretion of VEGF, IP-10 and 
MCP-1 within 72 h. TNF-α induced the secretion of IL-6, IP-10 and MCP-1, while IL-6 induced 
the secretion of VEGF and IL-10. 
 
3.4. IFN-γ and TNF-α stimulate the growth of single NPCs 
In addition to the analyses with the aggregate culture, the effects of IFN-γ and TNF-α to NPCs in 
single cell cultures were also studied (Fig 1, Exp 2). In single cell analyses, cells were studied with 
time-lapse imaging (Fig 5 A-D), a BrdU assay (Fig 5 E) and immunocytochemistry after 72 h 
treatments. Cell number analyses showed that IFN-γ at concentrations of 10 ng/ml and 100 ng/ml 
(coefficient 0.7, p<0.0001 and coefficient 0.2, p=0.048, respectively) significantly increased the 
neuronal migration during the 72 h follow-up compared with untreated samples (Fig 5 A). 
Likewise, TNF-α at concentrations of 10 ng/ml and 100 ng/ml (coefficient 0.5, p<0.0001 and 
coefficient 0.5, p<0.0001, respectively) significantly stimulated neuronal migration (Fig 5 B). 
However, only IFN-γ at a concentration of 10 ng/ml increased the neurite length compared with 
untreated samples (p<0.001, Fig 5 C).  
IFN-γ at a concentration of 100 ng/ml slightly decreased the cell proliferation after 72 h (p=0.032), 
while TNF-α at concentrations of 10 ng/ml and 100 ng/ml increased it (p=0.008 in both 
comparisons), compared with control cells (Fig 5 E). Finally, immunocytochemistry analyses did 
not show any effect on the number of nestin- or MAP-2-positive neuronal cells or GFAP- positive 
astrocytes (data not shown). 
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4. Discussion
In the present study, we were able to show that the proinflammatory cytokines IFN-γ, TNF-α, and 
IL-6 did not cause extensive cell death in human NPC cultures. In fact, increased proliferation was 
detected in TNF-α-treated NPCs. The NPCs responded to cytokine treatment by secreting the 
growth factor VEGF, the chemokines IP-10 and MCP-1, and the cytokines IL-6 and IL-10. The 
cytokine treatments also caused inhibition of spontaneous neuronal network activity. Thus, it 
seems that these cytokines modulate proliferation and both cellular and functional properties of 
human NPCs in vitro. 
The data about the effects of IFN-γ, TNF-α and IL-6 on neuronal cells is contradictory or has not 
been studied in details (Ben-Hur et al., 2003; Wong, Goldshmit and Turnley, 2004; Sheng et al., 
2005; Widera et al., 2006; Walter et al., 2011; Ye et al., 2013; Kulkarni, Ganesan and O’Donnell, 
2016). First, expression of receptors for the cytokines IFN-γ, TNF-α and IL-6 in NPCs were 
studied; these receptors are necessary to transduce the signals to the cells. All of them except 
TNFRSF1B were expressed constitutively in NPCs. Previously, it has been reported that both of 
the TNF receptors are constitutively expressed at the mRNA level in human NPCs, but at the 
protein level TNFRSF1A is more prominent (Sheng et al., 2005; Guadagno et al., 2013). Also 
protein expression of IFNGR1 has been reported (Mäkelä et al., 2010). Thereafter, the effects of 
the cytokines IFN-γ, TNF-α, and IL-6 on the viability of NPCs was studied, revealing that neither 
of the cytokine caused substantial cell death in human NPC sphere cultures. 
However, these cytokines influenced the proliferation of human NPCs. TNF-α increased 
proliferation, while IFN-γ decreased proliferation, in both single and aggregate cultures. In 
  18 
previous studies, TNF-α has contradictorily been shown to decrease, increase or have no effect on 
proliferation (Ben-Hur et al., 2003; Wong, Goldshmit and Turnley, 2004; Widera et al., 2006; 
Johansson, Price and Modo, 2008), while IFN-γ has either decreased or had no effect on 
proliferation (Ben-Hur et al., 2003; Wong, Goldshmit and Turnley, 2004; Widera et al., 2006; 
Johansson, Price and Modo, 2008). In consistent with our findings, a recent study showed that 
IFN-γ signaling via IFNGR1 and IFNGR2 receptors activates the JAK-STAT1 pathway, which 
eventually inhibits the proliferation of NPCs (Kulkarni, Ganesan and O’Donnell, 2016). TNF-α 
treatment has been shown to activate the nuclear factor kappa B pathway, which eventually leads 
to survival of the NPCs (Shih, Wang and Yang, 2015). However, discrepancies between reported 
results depend on many parameters, such as cell type, origin, media, and differentiation phase. 
Although the cytokines did not induce cell death of the NPC in vitro, in vivo situation might be 
different due to their effect also on the immune cells and CNS-resident cells like microglial cells 
and astrocytes. These cells may start to produce toxic substances like NO and complement 
components that are known to be toxic for the neuronal cells (Becher, Spath and Goverman, 2016). 
Moreover, it is noteworthy that used concentrations in this in vitro study (ng/ml) varies from the 
measured ones in vivo (pg/ml) and therefore extrapolating results directly to in vivo situation 
should be made with caution. Taken together, our data and those of others imply that IFN-γ and 
TNF-α can have pleiotropic effects on NPC survival and proliferation in vitro depending on their 
developmental and maturation stage and origin. This poses great challenges for transplantation 
therapies, as the inflammatory stage in the CNS can alter according to the disease stage, which 
further complicates the selection of optimal timing for transplantation.  
In addition to cell viability, IFN-γ and TNF-α have been shown to affect neuronal cell migration 
and neurite outgrowth in vitro (Ben-Hur et al., 2003; Wong, Goldshmit and Turnley, 2004). In 
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previous studies, neurons and neurites outgrowing from the plated aggregates were counted at a 
single timepoint. Here, we took advantage of automated time-lapse imaging and analysis 
(Huttunen et al., 2011) and performed continuous follow-up for 72 h after different cytokine 
treatments. IFN-γ slightly reduced the neuronal outgrowth rate from aggregates at a concentration 
of 10 ng/ml, while cell migration was not affected with the highest concentrations. In contrast to 
our study, Ben-Hur showed increased neuronal outgrowth at a 48 h timepoint after IFN-γ treatment 
(100 ng/ml) using newborn rat striatal NPCs (Ben-Hur et al., 2003). In addition, the neurite 
outgrowth was reduced after IFN-γ (1 and 10 ng/ml) treatment, in contrast to a study by Wong and 
colleagues (Wong, Goldshmit and Turnley, 2004) showing increased neurite outgrowth at a 72 h 
timepoint in IFN-γ-treated NPCs (100 ng/ml) derived from the supraventricular zone of adult mice. 
Since IFN-γ-treated NPCs inhibited cell proliferation as well as cell migration and neurite 
outgrowth from the aggregates, it is reasonable to conclude that IFN-γ has an inhibitory role in the 
cellular functions of NPCs. In addition, TNF-α-treated NPCs (100 ng/ml) showed reduced 
neuronal outgrowth from aggregates during 72 h follow up but did not show any other significant 
effects on neurite outgrowth. By contrast, Ben-Hur (Ben-Hur et al., 2003) found increased 
neuronal outgrowth in aggregates at a 48 h timepoint after TNF-α treatment (100 ng/ml) using 
newborn rat striatal NPCs. The effect of IL-6 on neuronal migration properties has not been 
addressed before. According to our results, it does not have any influence on neuronal or neurite 
outgrowth. In summary, it seems that IFN-γ and TNF-α can have more harmful effects on human 
neuronal migration properties than previously suggested.  
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Next, the effects of cytokine stimulation on the functionality of neuronal networks were studied. 
Previously, Walter and colleagues have shown that IFN-γ pretreatment for 7 days during early 
neuronal stem cell differentiation impairs the development of functional neuronal networks to a 
fully mature stage (Walter et al., 2011). In an extension of these results, we report that both IFN-
γ and TNF-α treatments tended to have biphasic effects on existing functional networks as they 
first stimulated and then inhibited the network functionality during the 72 h follow up. In line with 
our observation, recent reports have suggested that TNF-α enhances glutamate-mediated 
excitotoxicity of neuronal cells (Ye et al., 2013). In fact, spontaneous neuronal activity is inhibited 
by high concentrations of glutamate (Tukker et al., 2016). These data would suggest that if the aim 
of transplantation therapy is regeneration, inflammation needs to be controlled to levels at which 
the transplanted cells will be able to rebuild the existing circuits. 
NPCs in general are known be able to respond to inflammation not only by interacting with 
immune cells but also by secreting various factors that contribute to the bystander effects observed 
after transplantations (Pluchino and Cossetti, 2013). Interestingly, we were able to show that 
cytokine stimulation induced secretion of certain growth factors, cytokines and chemokines. 
Secretion of the growth factor VEGF, which is known to contribute to neuroprotection by reducing 
oxidative stress (Madhavan, Ourednik and Ourednik, 2008), was upregulated in IFN-γ- and IL-6-
treated NPCs after 72 h. In line with previous studies with human fetal NPCs (Sheng et al., 2005; 
Turbic, Leong and Turnley, 2011; Pugazhenthi et al., 2013), secretion of the chemokines MPC-1 
and IP-10 was detected in response to TNF-α and IFN-γ. Both MPC-1 and IP-10 are primarily 
known to regulate the migration of immune cells to damaged areas, but they also have regulatory 
effects on neuronal cell proliferation, survival and migration (De Haas et al., 2007). In addition, 
TNF-α induced IL-6 secretion; this response is most likely related to the activation of the nuclear 
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factor kappa B pathway, which mediates inflammatory events (Pugazhenthi et al., 2013; Cheng, 
Shen and Li, 2014) and thereby induces secretion of the proinflammatory cytokine IL-6 (Daniele 
et al., 2015). Production of the anti-inflammatory cytokine IL-10 was detected in IL-6-treated 
NPCs. IL-10 has key functions in balancing the pro- and anti-inflammatory responses, but it has 
also shown to reduce neuronal differentiation and ultimately to impair neurogenesis (Perez-
Asensio et al., 2013). Interestingly, the human NPCs seemed to have endogenous EGF secretion 
that was not affected by the cytokine stimulation, whereas endogenous FGF, PDGF-BB, NGF and 
IL-4 secretion was not detected within the detection limit of the method.   Moreover, it is possible 
that cytokine-treatment may induce secretion of several molecules at low levels, but they are 
quickly reabsorbed by the NPCs and were therefore undetectable.   Moreover, NPC cultures are 
never purely neuronal, in our study NPC culture consist 3% of the GFAP- positive astrocytes, 
therefore, it is likely that some of the cytokine-mediated effect comes from astrocyte activation 
(Roybon et al., 2013). The secretion of soluble factors by human NPCs most likely explains their 
good cell survival rates after cytokine treatments. 
Inflammatory cytokines did not have any effect on the differentiation of NPCs as determined by 
percentage of cells labeled against specific markers of neurons and astrocytes. The previous studies 
have shown contradictory results on whether these cytokines have any effect on differentiation 
(Ben-Hur et al., 2003; Wong, Goldshmit and Turnley, 2004; Widera et al., 2006); the discrepancies 
are most likely due to the different cells types used.  
Among the main challenges in NPC replacement therapies are the route of NPC administration 
and the form (small cell aggregates vs. single cells injections) of the NPCs. Most of the in vivo and 
in vitro studies of NPCs have been performed with NPC aggregates, and data about single cell 
cultures are lacking. Here, opposing effects were found in vitro when IFN-γ- and TNF-α-treated 
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NPCs were cultured in aggregates or single cell cultures. The decreased cell number in the NPC 
sphere study may be explained by the fact that NPCs are drawn back to their central sphere in an 
inflammatory environment. This might result in decreased cell number, because the total number 
of neurons could not be measured from the central aggregates. In both experiments, proliferation 
rates were on the same order of magnitude.  To conclude, IFN-γ seems to lack dose-dependent 
effect in cell migration and neurite outgrowth analysis in both aggregate and single cell cultures, 
since the most significant results were found with concentration 10 ng/ml in comparison to 
concentrations of 1 and 100 ng/ml. The observation may be related to biphasic function of IFN-γ, 
that need to study more detailed in the future studies. 
In conclusion, inflammatory cytokines appear to modulate proliferation as well as both cellular 
and functional properties of human NPCs in vitro. These aspects should be taken into account in 
in vitro and in vivo studies en route to the design of clinical treatments for MS. Additionally, as 
profound inflammation is a hallmark of many other neurodegenerative diseases and insults such 
as stroke, Alzheimer’s disease, and Parkinson’s disease, these results will also benefit studies in 
those areas. 
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Fig 1. Experimental design of the study (A) and characterization of NPCs (B-E). (A). hESCs 
were differentiated toward a neural lineage for 8-15 weeks and plated thereafter. In experiment 1 
(Exp 1), NPCs (cell lines HS181, 08/023, 06/040) were studied as aggregates, and in Exp2, the 
cells (cell line 08/023) were dissociated into single cells before plating (A).  NPCs were then 
treated with one of the cytokines IFN-γ, TNF-α, or IL-6 for 12, 24, 48, or 72 h. (B-E) 
Immunostaining of NPCs against MAP-2 (B), Nestin (C), MAP-2/NF-200 (D), GFAP (E) shows 
the representative figures of the Exp 1. DAPI stains nuclei blue. Scale bar 100 µm. 
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Fig 2. IFN-γ, TNF-α, and IL-6 did not affect the viability of the NPCs. (A-D) The effects of 
the cytokines IFN-γ (B), TNF-α (C), and IL-6 (D) and in the control conditions (A) on the viability 
of NPC aggregates were analyzed with a LIVE/DEAD® viability/cytotoxicity kit. Calcein-AM 
(green color) stains living cells, and ethidium homodimer-1 ( (EthD-1, red color) stains dead cells. 
Each sample shown here was treated with 100 ng/ml of a particular cytokine for 72 h (A-D). Scale 
bar 200 µm. (E) The gene expression levels of the cytokine receptors IFNGR1, IFNGR2, 
TNFRSF1A, TNFRSF1B, GP130 and IL6R were studied with RT-PCR. The figure illustrates the 
gene expression of cytokine receptors under the control conditions. RT-PCR analyses were 
performed from one sample per cytokine per cytokine concentration, while LIVE/DEAD® cell 
viability analyses were performed in at least 4 non-overlapping fields for each of two duplicate 
wells. 
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Fig 3. IFN-γ and TNF-α had effects on neuronal migration, neurite lengths, and proliferation. 
The effects of cytokines on neuronal migration (A-E) and NPC proliferation (F-I) were studied 
using time-lapse imaging (Cell-IQ) and immunocytochemistry, respectively. The NPCs were 
treated with IFN-γ, TNF-α, or IL-6 at concentrations 0, 1, 10, and 100 ng/ml for 72 h. In the Cell-
IQ analyses, the cells were imaged continuously 24 h before cytokine addition and for 72 h 
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thereafter (A-E). Neuronal migration was analyzed with a Poisson regression model (A-C), and 
neurite lengths with an ANOVA model (D-E). In the analyses, total 27 images  per cytokine per 
concentration were used in the analysis over 72h follow-up. Figures of cell number (A-C) and 
neurite length (D-E) were statistical model based that were adjusted with baseline measurement. 
For cell proliferation analysis (F-I), NPCs were double labeled for the proliferation marker Ki-67 
and neural stem and the progenitor cell marker nestin at 72h timepoint.  The cells were imaged 
and counted in at least from 4 non-overlapping fields of one well obtained with a 20× objective.  
The bar graph displays the mean (± SD) number of Ki-67+ cells out of all DAPI-positive cells (F). 
Representative figures of Ki-67+ (red color) co-labeling with nestin (green color, G-I) shows the 
100 ng/ml cytokine treatments at 72 h timepoint. DAPI stains nuclei blue. Scale bar 200 µm. 
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Fig 4. The effects of IFN-γ and TNF-α on the electrical activity of neural networks were 
studied using MEA. The figure illustrates a functional neuronal network and active electrodes 
(A-F). White electrodes represent actively signaling sites, and black electrodes detect no electrical 
signals. Normalized percentages of active channels for controls, IFN-γ-treated, and TNF-α-treated 
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neuronal networks on MEA. TNF- α (100ng/ml) inhibited neuronal network activity at the 72h 
timepoint (G). Representative examples of activity on MEA for control (0 h and 72 h) and TNF-
α-treated (100 ng/ml, 0 h and 72 h) neuronal networks (H). * p<0.05 compared with controls. The 
number of MEA wells per cytokine per concentration was 3-4. 
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Fig 5. The effects of IFN-γ and TNF-α on cell growth (A-D) and proliferation (E) in single 
cell NPC cultures were studied. In the Cell-IQ analyses, the cells were imaged continuously for 
24 h before the start of cytokine stimulation and for 72 h thereafter. Neuronal migration was 
analyzed with a Poisson regression model (A-B), and neurite growth with an ANOVA model (C-
D). Figures of cell number (A-B) and neurite length (C-D) were statistical model based that were 
adjusted with baseline measurement. The effects of the cytokines on cell proliferation were 
determined with ELISA-based BrdU proliferation analysis. Bar graphs display the mean (± SD) 
absorbance of samples after 72 h. In the live-imaging analysis, 27 images per cytokine per 
concentration were used in the analysis over 72h follow-up, while in the BrdU analysis the cells 
were collected from one well and 6 technical replicates were used. 
Table 1. The effect of IFN-γ TNF-α, and IL-6 on the secretion of growth factors, chemokines and cytokines from NPCs (B). Secreted 
molecules in the cell culture medium were measured using Luminex methodology  
IFN-γ TNF-α IL-6 
12h 72h 12h 72h 12h 72h 
0 
ng/ml 
10 
ng/ml 
100 
ng/ml 
0 
ng/ml 
10 
ng/ml 
100 
ng/ml 0 
10 
ng/ml 
100 
ng/ml 
0 
ng/ml 
10 
ng/ml 
100 
ng/ml 
0 
ng/ml 
10 
ng/ml 
100 
ng/ml 
0 
ng/ml 
10 
ng/ml 
100 
ng/ml 
EGF 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.33 0.4 0.4 0.4 0.4 0.4 
VEGF 2.3 0.1 3.2 7.1 37.5 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.00 0.0 0.0 0.2 20.9 12.3 
IP-10 2.4 0.0 24.4 0.0 84.6 65.5 0.0 42.8 84.4 0.0 182.8 304.2 0.00 0.0 0.0 0.0 0.0 0.0 
MCP-1 4.1 2.7 11.9 72.9 793.7 188.7 3.2 167.8 408.0 168.8 136.9 406.0 5.56 4.0 4.6 79.5 95.7 89.3 
IL-6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 14.6 10.9 0.00 0.0 0.0 0.0 0.0 0.0 
IL-10 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.00 0.3 0.5 0.0 0.4 0.4 
